Voyageur Pharmaceuticals (CVE:VM) Shares Up 47.4% – Still a Buy?

Voyageur Pharmaceuticals Ltd. (CVE:VMGet Free Report) was up 47.4% on Friday . The stock traded as high as C$0.14 and last traded at C$0.14. Approximately 1,312,210 shares traded hands during mid-day trading, an increase of 427% from the average daily volume of 249,010 shares. The stock had previously closed at C$0.10.

Voyageur Pharmaceuticals Price Performance

The company has a market capitalization of C$19.53 million, a PE ratio of -14.00 and a beta of 0.32. The company has a debt-to-equity ratio of 3.21, a current ratio of 0.17 and a quick ratio of 0.84. The stock’s 50 day simple moving average is C$0.08 and its 200-day simple moving average is C$0.06.

About Voyageur Pharmaceuticals

(Get Free Report)

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.

Further Reading

Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.